Quick Takeaways
- Amundi filed SCHEDULE 13G/A for Sanofi Common Stock and American Depositary Receipts (SNY).
- Disclosed ownership: 4.8%.
- Date of event: 31 Mar 2025.
Amundi - 31 Mar 2025 SCHEDULE 13G/A Report for Sanofi Common Stock and American Depositary Receipts (SNY)
- Filing Manager
- Amundi
- Reporting Manager
- AMUNDI
- Symbol
- SNY
- Shares outstanding
- 1,235,032,333 shares
- Disclosed Ownership
- 59,281,552 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2025, 16:50:16 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- Next filing
- 10 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Amundi disclosed 4.8% ownership in Sanofi Common Stock and American Depositary Receipts (SNY) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 12 May 2025, 16:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AMUNDI | 4.8% | 59,281,552 | 0 | 29,656,486 | /s/ John M. Malone | John M. Malone; Chief Compliance Officer | |
| Amundi Asset Management US, Inc. | 4.8% | 59,281,552 | 29,656,486 | /s/ John M. Malone | John M. Malone; Chief Compliance Officer |